IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Foresite Capital Opportunity Management V, LLC

Q4 2021 Holdings

Filed 2022-02-11 | 9 holdings | $30.0M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Cue Health Inc.(HLTHQ)COM229790100$20.5M1,527,10368.3%
Cullinan Oncology, Inc.(CGEM)COM230031106$5.9M381,00219.6%
Compass Therapeutics, Inc.(CMPX)COM20454B104$3.5M1,100,00011.6%
Pardes Biosciences IncCOM69945Q105$85.6K5,227,3070.3%
Quantum-Si Incorporated(QSI)COM CL A74765K105$12.6K1,598,1250.0%
Gemini Therapeutics, Inc.COM36870G105$7.1K2,435,1250.0%
Theseus Pharmaceuticals, Inc.COM88369M101$5.9K468,8200.0%
Kinnate Biopharma Inc.COM49705R105$5.2K291,6670.0%
Adicet Bio, Inc.(TORCEUR)COM007002108$3.0K170,0000.0%